-
Mashup Score: 1Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A large study found a benefit from combining the anti-PD-1 #immunecheckpointinhibitor #pembrolizumab with standard platinum-containing #chemo as initial therapy for patients with advanced HER2-negative gastric or gastroesophageal junction #cancer: https://t.co/qIuEjR15tg https://t.co/jrzADlTTOC
-
-
Mashup Score: 3Role of Cell-Free Urine and Plasma DNA Mutation Analysis in Predicting Neoadjuvant Chemotherapy Response and Outcomes in Patients With MIBC - 1 year(s) ago
Read it now on PracticeUpdate.com
Source: PracticeUpdateCategories: Hem/Oncs, Latest HeadlinesTweet-
Urine tumor (ut)-DNA (supernatant [supe] & pellet) & circulating tumor (ct)-DNA in muscle-invasive #bladdercancer receiving Neoadjuvant #Chemo (NAC)-#ctDNA before NAC, ctDNA/utDNA (supe/pellet) after NAC=lower response rate; ctDNA/utDNA-supe DNA dynamics https://t.co/53dDOEUNqa… https://t.co/QJzhXy7FiK
-
-
Mashup Score: 3Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A large study found a benefit from combining the anti-PD-1 #immunecheckpointinhibitor #pembrolizumab with standard platinum-containing #chemo as initial therapy for patients with advanced HER2-negative gastric or gastroesophageal junction #cancer: https://t.co/qIuEjR1DiO https://t.co/ZEXXtOVr4v
-
-
Mashup Score: 0
At 11.3 months of follow-up, magrolimab, rituximab, gemcitabine, and oxaliplatin yielded an overall response rate of 51.5%, including a complete response rate of 39.4%, among patients with relapsed or refractory diffuse large B-cell lymphoma.
Source: Oncology Nursing NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Magrolimab Plus Rituximab/Chemo Delivers Responses in Relapsed/Refractory DLBCL #chemo #magrolimab #oncology #nursing #DLBCL #lymsm #ASH22 https://t.co/4Kn3aof2ra
-
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Young #women with newly diagnosed aggressive #breastcancer lived twice as long with stable disease when treated with ribociclib plus a hormone-blocking drug compared to combination #chemo, according to results of the Phase II RIGHT Choice #clinicaltrial: https://t.co/zdkkV6751O https://t.co/Kh7wOAw95p
-
-
Mashup Score: 1New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer - 1 year(s) ago
AbstractBackground. Sedative-hypnotic medications are used to treat chemotherapy-related nausea, anxiety, and insomnia. However, prolonged sedative-hypnotic use
Source: OUP AcademicCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Does prolonged use of sedative-hypnotics like benzos lead to dependence, misuse, more healthcare use? This @JNCI_Now study estimates the rates of new persistent sedative-hypnotic use in #breastcancer patients on adjuvant #chemo. #bcsm Read more here: https://t.co/kTUhNpRYtI https://t.co/87VIRzmMKa
-
-
Mashup Score: 0LipidDoc’s Daily is out ! - 1 year(s) ago
Weekly news , posts and updates for Lipidology & Cardiovascular Disease Prevention by Dr. James Underberg
Source: paper.liCategories: Cardiologists, Latest HeadlinesTweet-
The latest LipidDoc's Daily is out !! https://t.co/Mm8ScJAmqJ Thanks to @ACCinTouch @JACCJournals @nationallipid #wccardio #chemo
-
-
Mashup Score: 2Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Young #women with newly diagnosed aggressive #breastcancer lived twice as long with stable disease when treated with ribociclib plus a hormone-blocking drug compared to combination #chemo, according to results of the Phase II RIGHT Choice #clinicaltrial: https://t.co/zdkkV6751O https://t.co/BgwOHX7Hu3
-
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Young #women with newly diagnosed aggressive #breastcancer lived twice as long with stable disease when treated with ribociclib plus a hormone-blocking drug compared to combination #chemo, according to results of the Phase II RIGHT Choice #clinicaltrial: https://t.co/zdkkV6751O https://t.co/6s9bCHLQ1y
-
#TBT: 3 QUESTIONS ON... Optimizing Cost-Effectiveness of #Chemo for Metastatic #BreastCancer With Stephanie Wheeler, PhD, MPH, at @UNC_Lineberger: https://t.co/Q4Gk2yAB2W #BCSM https://t.co/r3dHDlBjx2